júlí 2005

62 ELS tíðindi 7/05
(71) H. Lundbeck A/S, Ottiliavej 9, DK-
2500 Valby-Copenhagen, Danmörku.
(72) Hans Petersen, Vanløse; Robert
Dancer, Hvidovre; Brian Christiansen,
Frederiksberg; Rikke Eva Humble,
København; Danmörku.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 23.12.2002, DK, PA200202004
(85) 9.6.2005
(86) 18.12.2003, PCT/DK03/000907
(21) 7887
(22) 9.6.2005
(41) 9.6.2005
(51) C25C 3/16
(54) Bakskauts kerfi fyrir raflausnar
framleiðslu á áli.
(71) SGL Carbon AG, Rheingaustrasse
182, D-65203 Wiesbaden,
Þýskalandi.
(72) Manfred Banek, Kriftel, Þýskalandi.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 30.12.2002, DE, 102 61 745.7
(85) 9.6.2005
(86) 18.12.2003, PCT/EP03/014558
(21) 7888
(22) 10.6.2005
(41) 10.6.2005
(51) A61K 9/00
(54) Fínasteríðsamsetningar.
(71) Actavis Group hf., Reykjavíkurvegi
76, 220 Hafnarfirði, Íslandi.
(72) Fjalar Jóhannsson; Birkir Árnason;
Reykjavík, Íslandi.
(74) A&P Árnason ehf., Efstaleiti 5, 103
Reykjavík.
(30) 22.11.2002, IS, 6633
(85) 10.6.2005
(86) 21.11.2003, PCT/IS2003/000034
(21) 7889
(22) 10.6.2005
(41) 10.6.2005
(51) A61K 9/24
(54) Lagskipt tafla, sem inniheldur
pravastatín og aspirín, og aðferð.
(71) Bristol-Myers Squibb Company,
P.O. Box 4000, Route 206 and
Province Line Road, Princeton, New
Jersey 08543-4000, Bandaríkjunum.
(72) Admassu Abebe, Orvault,
Frakklandi; Loutfy Benkerrour, Paris,
Frakklandi; Olivier Galley, Pornichet,
Frakklandi; Francoise Quinet,
Nantes, Frakklandi; Peter Timmins,
Nocturum, Prenton, Merseyside,
Bretlandi.
(74) Kjartan Ragnars, hrl., Hrauntungu
66, 200 Kópavogi.
(30) 11.12.2002, US, 10/316,424
(85) 10.6.2005
(86) 3.12.2003, PCT/US2003/038774
(21) 7890
(22) 10.6.2005
(41) 10.6.2005
(51) C07D 487/04; A61K 31/53; A61P 13/
08; A61P 29/00; A61P 37/00
(54) C-6 breytt indazólýlpýrrólótríazín.
(71) Bristol-Myers Squibb Company,
P.O. Box 4000, Route 206 and
Province Line Road, Princeton, New
Jersey 08543-4000, Bandaríkjunum.
(72) Gregory D. Vite, Titusville, New
Jersey; Ashvinikumar V. Gavai,
Princeton Junction, New Jersey;
Brian E. Fink, Princeton Junction,
New Jersey; Harold Mastalerz,
Guilford, Connecticut; John F.
Kadow, Wallingford, Connecticut;
Bandaríkjunum.
(74) Kjartan Ragnars, hrl., Hrauntungu
66, 200 Kópavogi.
(30) 13.12.2002, US, 60/433,190
(85) 10.6.2005
(86) 12.12.2003, PCT/US2003/039542
(21) 7891
(22) 10.6.2005
(41) 10.6.2005
(51) A61K 31/437; A61K 31/435; A61K
31/55; C07D 471/04; C07D 487/04;
A61P 25/00; A61P 3/04
(54) Skiptitengd þrísýklísk gammakarbólín
sem serótónín viðtaka
gerandefni og mótverkunarefni.
(71) Bristol-Myers Squibb Company,
P.O. Box 4000, Route 206 and
Province Line Road, Princeton, New
Jersey 08543-4000, Bandaríkjunum.
(72) Taekyu Lee, Doylestown,
Pennsylvania; Wenting Chen,
Langhorne, Pennsylvania; Wei
Deng, Lexington, Massachusetts;
Albert Robichaud, Ringoes, New
Jersey; Ruth Wexler, Belle Mead,
New Jersey; Bandaríkjunum.
(74) Kjartan Ragnars, hrl., Hrauntungu
66, 200 Kópavogi.
(30) 19.12.2002, US, 60/434,760
(85) 10.6.2005
(86) 19.12.2003, PCT/US2003/041447
(21) 7892
(22) 13.6.2005
(41) 13.6.2005
(51) C07D 471/04; A61K 31/519; A61P
31/18; C07D 487/04
(54) Tetrahýdró-4H-pýridó[1,2-
A]pýrimidín og tengd efnasambönd
sem nýtast sem HIV integrasa
hindrar.
(71) Istituto di Ricerche di Biologia,
Molecolare P. Angeletti Spa, Via
Pontina Km. 30,600, I-00040
Pomezia, Ítalíu.
(72) Benedetta Crescenzi; Olaf Kinzel;
Ester Muraglia; Federica Orvieto;
Giovanna Pescatore; Michael
Rowley; Vincenzo Summa; Pomezia,
Ítalíu.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 27.12.2002, US, 60/436,830
12.12.2003, US, 60/528,776
(85) 13.6.2005
(86) 18.12.2003, PCT/GB03/005543
(21) 7893
(22) 14.6.2005
(41) 14.6.2005
(51) C07K 5/062; A61K 38/05; A61P 9/00
(54) Perindópríl.
(71) Cipla Ltd., 289 Bellasis Road,
Mumbai Central, Mumbai 400 008,
Indlandi.
(72) Dharmaraj Ramachandra Rao;
Rajendra Narayanrao Kankan;
Mumbai, Maharashtra, Indlandi.
(74) Kjartan Ragnars, hrl., Hrauntungu
66, 200 Kópavogi.
(30) 18.11.2002, GB, 0226885.2
(85) 14.6.2005
(86) 18.11.2003, PCT/GB2003/004981
(21) 7894
(22) 14.6.2005
(41) 14.6.2005
(51) A61K 9/00; A61K 39/35; A61K 47/26;
A61K 47/36; A61K 47/42
(54) Skammtaform með ofnæmisvaka.
(71) Alk-Abelló A/S, Bøge Allé 6-8, DK-
2970 Hørsholm, Danmörku.
(72) Henrik Hugo Jacobi, Vedbæk;
Annette Rømmelmayer, Søborg;
Christian Gauguin Houghton,
Gentofte; Stig Aasmul-Olsen,
Skodsborg; Lise Lund Mærkedahl,
Fredensborg; Jan Søndergaard
Andersen, Hillerød; Danmörku.
(74) A&P Árnason ehf., Efstaleiti 5, 103
Reykjavík.
(30) 26.11.2002, DK, PA 2002 01825
26.11.2002, US, 60/429,086
24.2.2003, DK, PA 2003 00279
(85) 14.6.2005
(86) 26.11.2003, PCT/DK2003/000814
(21) 7896
(22) 16.6.2005
(41) 16.6.2005
(51) C07D 309/32; C07D 405/06; C07D
409/10; C07D 413/10; C07D 407/10;
C07D 413/12; C07D 407/06; C07D
405/12; C07D 407/12; C07D 417/10;
C07D 409/06; C07D 471/04; C07D
487/04; C07D 285/06; C07D 405/10;
C07D 413/06; C07D 417/06; C07D
495/04; C07D 513/04; C07D 405/14;
C07D 413/14; C07D 417/12; C07D
473/36; C07D 473/30; A61K 31/351;
A61P 31/14
(54) Latar á lifrarbólgu C vírus
ríbósakjarnsýru-háðu
ríbósakjarnsýru liðunarensími, og
samsetningar og meðferðir sem nota
þá..
(71) Pfizer Inc. , 235 East 42nd Street,
New York, New York 10017,
Bandaríkjunum.
(72) Allen John Borchardt; Javier
Gonzalez; Hui Li; Maria Angelica
Linton; John Howard Tatlock; San
Diego, California, Bandaríkjunum.
(74) Faktor einkaleyfaskrifstofa, ehf.,
Pósthólf 678, 121 Reykjavík.
(30) 21.2.2003, US, 60/449,088
20.5.2003, US, 60/472,355
(85) 16.6.2005
(86) 9.2.2004, PCT/IB04/000493